Johnson & Johnson (JNJ) closed at $285.75 on November 13, 2026, up 0.8% from the previous close, on volume of 5,326,721 shares (30-day average 7,771,074).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 23, 2026 | Put Spread | 30-Oct-26255 : 260 P | 21,820 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
U.S. Stocks Finish in the Red as the AI Trade Falters
TipRanks (Fri, 13-Nov 4:03 PM ET)
TipRanks (Thu, 12-Nov 6:30 AM ET)
TipRanks (Thu, 12-Nov 6:15 AM ET)
Democratic senators probe gifts to RFK Jr. from large donor to his presidential campaign
Seeking Alpha News (Wed, 11-Nov 3:39 PM ET)
Halozyme downgraded at Morgan Stanley on valuation
Seeking Alpha News (Wed, 11-Nov 12:09 PM ET)
Globe Newswire (Tue, 10-Nov 6:35 PM ET)
J&J succeeds in second late-stage trial for Caplyta in bipolar mania
Seeking Alpha News (Tue, 10-Nov 8:42 AM ET)
PRNewswire (Tue, 10-Nov 8:01 AM ET)
TipRanks (Tue, 10-Nov 3:00 AM ET)
TipRanks (Mon, 9-Nov 3:16 PM ET)
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Johnson & Johnson trades on the NYSE stock market under the symbol JNJ.
As of November 13, 2026, JNJ stock price climbed to $285.75 with 5,326,721 million shares trading.
JNJ has a beta of -0.42, meaning it tends to be less sensitive to market movements. JNJ has a correlation of 0.05 to the broad based SPY ETF.
JNJ has a market cap of $688.09 billion. This is considered a Mega Cap stock.
Last quarter Johnson & Johnson reported $25 billion in Revenue and $2.59 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.06.
In the last 3 years, JNJ traded as high as $288.11 and as low as $140.68.
The top ETF exchange traded funds that JNJ belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
JNJ has outperformed the market in the last year with a price return of +49.1% while the SPY ETF gained +13.4%. JNJ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +9.5% and +4.6%, respectively, while the SPY returned -2.8% and -0.2%, respectively.
JNJ support price is $278.31 and resistance is $288.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JNJ shares will trade within this expected range on the day.
